Clinically, large diameter artery defects (diameter larger than 6 mm) can be substituted by unbiodegradable polymers, such as polytetrafluoroethylene. There are many problems in the construction of small diameter blood vessels (diameter between 1 and 3 mm) and microvessels (diameter less than 1 mm), especially in the establishment of complex vascular models with multi-scale branched networks. Throughout history, the vascularization strategies have been divided into three major groups, including self-generated capillaries from implantation, pre-constructed vascular channels, and three-dimensional (3D) printed cell-laden hydrogels. The first group is based on the spontaneous angiogenesis behaviour of cells in the host tissues, which also lays...
There has been an increasing demand for bioengineered blood vessels for utilization in both regenera...
One of the challenging issues in tissue engineering is a building of functional vascular network sys...
The broad clinical use of synthetic vascular grafts for vascular diseases is limited by their thromb...
Clinically, large diameter artery defects (diameter larger than 6 mm) can be substituted by unbiodeg...
A basic prerequisite for the survival and function of three-dimensional (3D) engineered tissue const...
A basic prerequisite for the survival and function of three-dimensional (3D) engineered tissue const...
Free-form fabrication techniques, often referred to as ‘3D printing’, are currently tested with rega...
In recent years, tissue engineering has achieved significant advancements towards the repair of dama...
3D bioprinting is currently used for developing oncological research models such as organ-on-chip or...
In recent years, tissue engineering has achieved significant advancements towards the repair of dama...
Vascular disease – including coronary artery disease, carotid artery disease, and peripheral vascula...
Cardiovascular diseases are one of the major causes of mortality throughout the world. Availability ...
Microfabrication technologies have been proposed as methods to create vascularized tissues. However,...
Microfabrication technologies have been proposed as methods to create vascularized tissues. However,...
Among advanced therapy medicinal products, tissue-engineered products have the potential to address ...
There has been an increasing demand for bioengineered blood vessels for utilization in both regenera...
One of the challenging issues in tissue engineering is a building of functional vascular network sys...
The broad clinical use of synthetic vascular grafts for vascular diseases is limited by their thromb...
Clinically, large diameter artery defects (diameter larger than 6 mm) can be substituted by unbiodeg...
A basic prerequisite for the survival and function of three-dimensional (3D) engineered tissue const...
A basic prerequisite for the survival and function of three-dimensional (3D) engineered tissue const...
Free-form fabrication techniques, often referred to as ‘3D printing’, are currently tested with rega...
In recent years, tissue engineering has achieved significant advancements towards the repair of dama...
3D bioprinting is currently used for developing oncological research models such as organ-on-chip or...
In recent years, tissue engineering has achieved significant advancements towards the repair of dama...
Vascular disease – including coronary artery disease, carotid artery disease, and peripheral vascula...
Cardiovascular diseases are one of the major causes of mortality throughout the world. Availability ...
Microfabrication technologies have been proposed as methods to create vascularized tissues. However,...
Microfabrication technologies have been proposed as methods to create vascularized tissues. However,...
Among advanced therapy medicinal products, tissue-engineered products have the potential to address ...
There has been an increasing demand for bioengineered blood vessels for utilization in both regenera...
One of the challenging issues in tissue engineering is a building of functional vascular network sys...
The broad clinical use of synthetic vascular grafts for vascular diseases is limited by their thromb...